| Literature DB >> 23954338 |
K Lance Gould1, Nils P Johnson2, Timothy M Bateman3, Rob S Beanlands4, Frank M Bengel5, Robert Bober6, Paolo G Camici7, Manuel D Cerqueira8, Benjamin J W Chow4, Marcelo F Di Carli9, Sharmila Dorbala9, Henry Gewirtz10, Robert J Gropler11, Philipp A Kaufmann12, Paul Knaapen13, Juhani Knuuti14, Michael E Merhige15, K Peter Rentrop16, Terrence D Ruddy4, Heinrich R Schelbert17, Thomas H Schindler18, Markus Schwaiger19, Stefano Sdringola2, John Vitarello20, Kim A Williams21, Donald Gordon22, Vasken Dilsizian23, Jagat Narula24.
Abstract
Angiographic severity of coronary artery stenosis has historically been the primary guide to revascularization or medical management of coronary artery disease. However, physiologic severity defined by coronary pressure and/or flow has resurged into clinical prominence as a potential, fundamental change from anatomically to physiologically guided management. This review addresses clinical coronary physiology-pressure and flow-as clinical tools for treating patients. We clarify the basic concepts that hold true for whatever technology measures coronary physiology directly and reliably, here focusing on positron emission tomography and its interplay with intracoronary measurements.Entities:
Keywords: CAD; CFR; ECG; FFR; MI; PCI; PET; PET perfusion imaging; SPECT; coronary artery disease; coronary flow; coronary flow reserve; coronary physiology; electrocardiographic/electrocardiography; fractional flow reserve; ischemia; myocardial infarction; percutaneous intervention; positron emission tomography; revascularization; single-photon emission computed tomography
Mesh：
Year: 2013 PMID： 23954338 DOI： 10.1016/j.jacc.2013.07.076
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094